Mice with experimental colitis show an altered metabolism with decreased metabolic rate

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 292, Issue 1, 2007, Pages

  Melgar, Silvia ^a   Bjursell, Mikael ^a,b   Gerdin, Anna Karin ^a   Svensson, Lennart ^a   Michaëlsson, Erik ^a   Bohlooly Y, Mohammad ^a  

^a ASTRAZENECA R AND D   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Colon inflammation; Dextran sulfate sodium; Dual energy X ray absorptiometry; Respiratory exchange ratio

Indexed keywords

CARBOHYDRATE; DEXTRAN SULFATE; LIPID; METHYLPREDNISOLONE; OSTEOCALCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY FAT; BODY WEIGHT; BONE DENSITY; COLITIS; CONTROLLED STUDY; DISEASE MARKER; DUAL ENERGY X RAY ABSORPTIOMETRY; ENERGY RESOURCE; ENTERITIS; FAT CONTENT; FEMALE; FOOD INTAKE; INFLAMMATION; LIPID METABOLISM; LOCOMOTION; LUNG GAS EXCHANGE; METABOLIC RATE; MOUSE; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL;

ALANINE TRANSAMINASE; ANIMALS; BODY COMPOSITION; CHOLESTEROL; COLITIS; COLON; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; INFLAMMATORY BOWEL DISEASES; MALE; METHYLPREDNISOLONE; MICE; MICE, INBRED C57BL; TRIGLYCERIDES;

EID: 33846172012     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00152.2006     Document Type: Article

References (34)

1. Bjursell M, Gerdin AK, Ploj K, Svensson D, Svensson L, Oscarsson J, Snaith M, Tornell J, Bohlooly-Y M. Melanin-concentrating hormone receptor 1 deficiency increases insulin sensitivity in obese leptin-deficient mice without affecting body weight. Diabetes 55: 725-733, 2006.
2. Blumberg RS, Saubermann LJ, Strober W. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol 11: 648-656, 1999. [Erratum. Curr Opin Immunol 12 (2): 226, 2006.]
3. Bohlooly-Y M, Olsson B, Bruder CEG, Linden D, Sjogren K, Bjursell M, Egecioglu E, Svensson L, Brodin P, Waterton JC, Isaksson OGP, Sundler F, Ahren B, Ohlsson C, Oscarsson J, Tornell J. Growth hormone overexpression in the central nervous system results in hyperphagia-induced obesity associated with insulin resistance and dyslipidemia. Diabetes 54: 51-62, 2005.
4. Breuille D, Voisin L, Contrepois M, Arnal M, Rose F, Obled C. A sustained rat model for studying the long-lasting catabolic state of sepsis. Infect Immun 67: 1079-1085, 1999.
5. Byrne FR, Morony S, Warmington K, Geng Z, Brown HL, Flores SA, Fiorino M, Yin SL, Hill D, Porkess V, Duryea D, Pretorius JK, Adamu S, Manuokian R, Danilenko DM, Sarosi I, Lacey DL, Kostenuik PJ, Senaldi G. CD4+CD45RBHi T cell transfer induced colitis in mice is accompanied by osteopenia which is treatable with recombinant human osteoprotegerin. Gut 54: 78-86, 2005.
6. Capristo E, Mingrone G, Addolorato G, Greco AV, Gasbarrini G. Metabolic features of inflammatory bowel disease in a remission phase of the disease activity. J Intern Med 243: 339-347, 1998.
7. Capristo E, De Gaetano A, Mingrone G, Addolorato G, Greco AV, Castagneto M, Gasbarrini G. Multivariate identification of metabolic features in inflammatory bowel disease. Metabolism 48: 952-956, 1999.
8. Chan AT, Fleming CR, O'Fallon WM, Huizenga KA. Estimated versus measured basal energy requirements in patients with Crohn's disease. Gastroenterology 91: 75-78, 1986.
9. Dresner-Pollak R, Rachmilewitz D, Karmeli F, Weinreb M. Interleukin 10-deficient mice develop osteopenia, decreased bone formation, and mechanical fragility of long bones. Gastroenterology 127: 792-801, 2004.
10. Feingold K, Hardardottir I, Memon R, Krul E, Moser A, Taylor J, Grunfeld C. Effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters. J Lipid Res 34: 2147-2158, 1993.
11. Feingold K, Staprans I, Memon R, Moser A, Shigenaga J, Doerrler W, Dinarello C, Grunfeld C. Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J Lipid Res 33: 1765-1776, 1992.
12. Fisher RL. Wasting in chronic gastrointestinal diseases. J Nutr 129, Suppl 1S: 252S-255S, 1999.
13. Frei P, Fried M, Hungerbü hler V, Rammert C, Rousson V, and Kullak-Ublick GA. Analysis of risk factors for low bone mineral density in inflammatory bowel disease. Digestion 73: 40-46, 2006.
14. Gaetke LM, Oz HS, de Villiers WJS, Varilek GW, Frederich RC. The leptin defense against wasting is abolished in the IL-2-deficient mouse model of inflammatory bowel disease. J Nutr 132: 893-896, 2002.
15. Ghosh S, Cowen S, Hannan WJ, Ferguson A. Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. Gastroenterology 107: 1031-1039, 1994.
16. Jahnsen J, Falch J, Aadland E, Mowinckel P. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. Gut 40: 313-319, 1997.
17. Kanai T, Kawamura T, Dohi T, Makita S, Nemoto Y, Totsuka T, Watanabe M. TH1/TH2-mediated colitis induced by adoptive transfer of CD4+CD45RBhigh T lymphocytes into nude mice. Inflamm Bowel Dis 12: 89-99, 2006.
18. Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR, Grunfeld C. Thematic review series: the pathogenesis of atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host. J Lipid Res 45: 1169-1196, 2004.
19. Krok KL, Lichtenstein GR. Nutrition in Crohn's disease. Curr Opin Gastroenterol 19: 148-153, 2003.
20. Larsson AE, Melgar S, Rehnstrom E, Michaelsson E, Svensson L, Hockings P, Olsson LE. Magnetic resonance imaging of experimental mouse colitis and association with inflammatory activity. Inflamm Bowel Dis 12: 478-485, 2006.
21. Lin CL, Moniz C, Chambers TJ, Chow JW. Colitis causes bone loss in rats through suppression of bone formation. Gastroenterology 111: 1263-1271, 1996.
22. Linden J, Korkalainen M, Lensu S, Tuomisto J, Pohjanvirta R. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and leptin on hypothalamic mRNA expression of factors participating in food intake regulation in a TCDD-sensitive and a TCDD-resistant rat strain. J Biochem Mol Toxicol 19: 139-148, 2005.
23. Melgar S, Karlsson A, Michaelsson E. Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am J Physiol Gastrointest Liver Physiol 288: G1328-G1338, 2005.
24. Mercier S, Breuille D, Mosoni L, Obled C, and Patureau Mirand P. Chronic inflammation alters protein metabolism in several organs of adult rats. J Nutr 132: 1921-1928, 2002.
25. Messina G, Viceconti N, Trinti B. [The clinical and echographic assessment of thyroid function and structure in patients with a chronic inflammatory intestinal disease]. Recenti Prog Med 90: 13-16, 1999.
26. Mingrone G, Greco AV, Benedetti G, Capristo E, Semeraro R, Zoli G, Gasbarrini G. Increased resting lipid oxidation in Crohn's disease. Dig Dis Sci 41: 72-76, 1996.
27. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98: 694-702, 1990.
28. Podolsky DK. Inflammatory bowel disease. N Engl J Med 347: 417-429, 2002.
29. Royall D, Greenberg GR, Allard JP, Baker JP, Jeejeebhoy KN. Total enteral nutrition support improves body composition of patients with active Crohn's disease. J Parenter Enteral Nutr 19: 95-99, 1995.
30. Simpson EJ, Chapman MAS, Dawson J, Berry D, Macdonald IA, Cole A. In vivo measurement of colonic butyrate metabolism in patients with quiescent ulcerative colitis. Gut 46: 73-77, 2000.
31. Sjogren K, Hellberg N, Bohlooly-Y M, Savendahl L, Johansson MS, Berglindh T, Bosaeus I, Ohlsson C. Body fat content can be predicted in vivo in mice using a modified dual-energy X-ray absorptiometry technique. J Nutr 131: 2963-2966, 2001.
32. Tjellesen L, Nielsen PK, Staun M. Body composition by dual-energy X-ray absorptiometry in patients with Crohn's disease. Scand J Gastroenterol 33: 956-960, 1998.
33. von Allmen D, Hasselgren PO, Higashiguchi T, Frederick J, Zamir O, Fischer JE. Increased intestinal protein synthesis during sepsis and following the administration of tumour necrosis factor alpha or interleukin-1 alpha. Biochem J 286: 585-589, 1992.
34. Wong S, Pinkney J. Role of cytokines in regulating feeding behaviour. Curr Drug Targets 5: 251-263, 2004.